VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/15

Supreme Pharmaceuticals Inc. (the "Company") (OTC PINK: SPRWF)(CSE: SL) advises that it has settled outstanding debts by the issuance of 500,000 shares at a deemed price of $0.3375 per share. These shares shall be subject to a 4 month trading restriction.

Contacts:
Supreme Pharmaceuticals Inc.
Investor Relations
(604) 674-2191
info@supreme.ca
www.supreme.ca